Another EVA Insider Reports a Share Buy
RA Capital Management LP filed an amended 13G for Inhibrx Inc $INBX revealing an increase in ownership from 5.6% to 8.16%.
Here’s The Hot List, with data through October 17, 2022:
In yet another Form 4 for Enviva $EVA, Director John Bumgarner Jr reported a purchase worth roughly $162,756.
This comes on the heels of five Form 4 filings yesterday and another handful from Friday.
Activists have also built a large position in the stock recently. It goes without saying, all this insider activity in Enviva is incredibly bullish.
In the options market, there was bullish flow in:
- Agrify $AGFY
- Ally Financial $ALLY
- CTI BioPharma $CTIC
- Coeur Mining $CDE
- B&G Foods $BGS
Stay tuned. We'll be back Wednesday with more insider action.
If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team